A case series of transformation of teratoma to primitive neuroectodermal tumor: evolving management of a rare malignancy

by Richard F. Dunne, Deepak M. Sahasrabudhe, Edward M. Messing, Jerome Jean-Gilles, Chunkit Fung
Published 2014-03-01

Complete remission of locally adComplete remission of locally advanced penile squamous cell carcinoma after multimodality treatment

by Yifan Meng, Helen Levey Bernie, Tzu-Hua Weng, Dean-An Ling, Edward M. Messing, Elizabeth Guancial
Published 2016-12-01

Risk of adverse pathological features for intermediate risk prostate cancer: Clinical implications for definitive radiation therapy.

by Hong Zhang, Christopher Doucette, Hongmei Yang, Sanjukta Bandyopadhyay, Craig E Grossman, Edward M Messing, Yuhchyau Chen
Published 2021-01-01

Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.

by Elizabeth A Guancial, Deepak Kilari, Guang-Qian Xiao, Sohaib H Abu-Farsakh, Andrea Baran, Edward M Messing, Eric S Kim
Published 2016-01-01

Age and Racial Differences Among PSA-Detected (AJCC Stage T1cN0M0) Prostate Cancer in the U.S.: A Population-Based Study of 70,345 Men

by Hong eZhang, Edward M Messing, Lois B Travis, Ollivier eHyrien, Rui eChen, Michael T Milano, Yuhchyau eChen
Published 2013-12-01

TRAIL-coated leukocytes to kill circulating tumor cells in the flowing blood from prostate cancer patients

by Nerymar Ortiz-Otero, Jocelyn R. Marshall, Antonio Glenn, Jubin Matloubieh, Jean Joseph, Deepak M. Sahasrabudhe, Edward M. Messing, Michael R. King
Published 2021-08-01